Invention Grant
- Patent Title: Adjuvant theraphy of G250-expressing tumors
- Patent Title (中): G250表达肿瘤的辅助治疗
-
Application No.: US11630170Application Date: 2005-06-29
-
Publication No.: US07691375B2Publication Date: 2010-04-06
- Inventor: Olaf Wilhelm , Sven Warnaar
- Applicant: Olaf Wilhelm , Sven Warnaar
- Applicant Address: DE Munich
- Assignee: Wilex AG
- Current Assignee: Wilex AG
- Current Assignee Address: DE Munich
- Agency: Rothwell, Figg, Ernst & Manbeck, P.C.
- International Application: PCT/EP2005/006994 WO 20050629
- International Announcement: WO2006/002889 WO 20060112
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/00
Abstract:
The invention relates to a method for the treatment of G250-antigen-expressing tumors, in particular renal clear cell carcinoma comprising the administration of G250-antigen-specific antibodies to high-risk patients diagnosed with non-metastasizing disease.
Public/Granted literature
- US20070207157A1 Adjuvant Theraphy of G250-Expressing Tumors Public/Granted day:2007-09-06
Information query
